Damora Therapeutics, Inc.
Company Stats
- Market Cap
- $1.3B
- as of Sep 30, 2026
- Shares Outstanding
- 61.7M
- Free Float
- 78.5%
Income Statement
- Operating Income
- -$210.9M
- Net Income
- -$209.8M
- EBITDA
- -$210.8M
Balance Sheet
- Cash & Equivalents
- $257.6M
Returns & Capital
- SBC, 3Y Avg
- $3.2M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2022 | — | -$43.1M | — |
| FY2021 | — | -$52.5M | — |
Annual filing data through FY ended December 31, 2025; shares and float as of October 14, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.